Table 1.
Ref. | Study (first author) | Year | Factor | Site/Organ | |
---|---|---|---|---|---|
Test-retest | [34] | Du et al. | 2019 | NSCLC | |
[35] | Mahon et al. | 2019 | NSCLC | ||
[36] | Tanaka et al. | 2019 | Lung cancer | ||
[37] | Tunali et al. | 2019 | NSCLC | ||
[38] | Zwanenburg et al. | 2019 | NSCLC, HNSCC | ||
[39] | Berenguer et al. | 2018 | Phantom | ||
[40] | Desseroit et al. | 2017 | NSCLC | ||
[41] | Larue et al. | 2017 | Phantom | ||
[42] | Larue et al. | 2017 | NSCLC, esophageal cancer | ||
[43] | Hu et al. | 2016 | Rectal cancer | ||
[32] | van Timmeren et al. | 2016 | NSCLC, rectal cancer | ||
[44] | Aerts et al. | 2014 | NSCLC | ||
[45] | Balagurunathan et al. | 2014 | NSCLC | ||
[46] | Balagurunathan et al. | 2014 | NSCLC | ||
[47] | Fried et al. | 2014 | NSCLC | ||
[48] | Hunter et al. | 2013 | NSCLC | ||
Acquisition | [49] | Hepp et al. | 2020 | Dose | NSCLC |
[50] | Piazzese et al. | 2019 | Contrast | Oesophageal cancer | |
[51] | Robins et al. | 2019 | Dose | Simulated lesions | |
[36] | Tanaka et al. | 2019 | Breathing | Lung cancer | |
[39] | Berenguer et al. | 2018 | Scanner, kVp, mAs, pitch, FOV, acq. mode | Phantom | |
[52] | Ger et al. | 2018 | Scanner | Phantom | |
[53] | Mackin et al. | 2018 | mAs | Phantom | |
[54] | Shafiq-ul-Hassan et al. | 2018 | Scanner | Phantom | |
[55] | Buch et al. | 2017 | kVp, mAs, pitch, acq. mode | Phantom | |
[41] | Larue et al. | 2017 | Scanner, mAs | Phantom | |
[42] | Larue et al. | 2017 | Breathing | NSCLC, esophageal cancer | |
[56] | Mackin et al. | 2017 | Scanner | Phantom | |
[57] | Shafiq-ul-Hassan et al. | 2017 | mAs, pitch | Phantom | |
[58] | Lo et al. | 2016 | mAs | Phantom, lung nodules | |
[59] | Solomon et al. | 2016 | Dose | Liver, lung nodules, renal stones | |
[60] | Fave et al. | 2015 | kVp, mAs, Breathing | NSCLC | |
[61] | Oliver et al. | 2015 | Breathing | Lung cancer | |
[48] | Hunter et al. | 2013 | Breathing | NSCLC | |
Reconstruction | [62] | Choe et al. | 2019 | Kernel | Pulmonary nodules |
[50] | Piazzese et al. | 2019 | 2D/3D | Oesophageal cancer | |
[63] | Ligero et al. | 2019 | Kernel | Different tumor sites | |
[51] | Robins et al. | 2019 | Voxel size, kernel | Simulated lesions | |
[64] | Varghese et al. | 2019 | Voxel size, filtering | Phantom | |
[39] | Berenguer et al. | 2018 | Voxel size, kernel | Phantom | |
[54] | Shafiq-ul-Hassan et al. | 2018 | Voxel size | Phantom | |
[55] | Buch et al. | 2017 | Voxel size | Phantom | |
[41] | Larue et al. | 2017 | Voxel size | Phantom | |
[56] | Mackin et al. | 2017 | Voxel size | Phantom | |
[57] | Shafiq-ul-Hassan et al. | 2017 | Kernel | Phantom | |
[65] | Bogowicz et al. | 2016 | Voxel size, calculation factors* | NSCLC, oropharyngeal carcinoma | |
[66] | Kim et al. | 2016 | Algorithm | Pulmonary tumors | |
[58] | Lo et al. | 2016 | Kernel | Phantom, lung nodules | |
[67] | Lu et al. | 2016 | Algorithm, voxel size | Lung cancer | |
[59] | Solomon et al. | 2016 | Algorithm | Liver, lung nodules, renal stones | |
[68] | Zhao et al. | 2016 | Algorithm, voxel size | Lung cancer | |
[60] | Fave et al. | 2015 | 2D/3D | NSCLC | |
[69] | Kim et al. | 2015 | Algorithm | Phantom | |
[70] | Zhao et al. | 2014 | Voxel size, kernel | Phantom | |
Segmentation | [62] | Choe et al. | 2019 | Pulmonary nodules | |
[63] | Ligero et al. | 2019 | Different tumor sites | ||
[71] | Qiu et al. | 2019 | Hepatocellular carcinoma | ||
[37] | Tunali et al. | 2019 | NSCLC | ||
[72] | Pavic et al. | 2018 | Mesothelioma, NSCLC, HN | ||
[73] | Kalpathy-Cramer et al. | 2016 | Lung nodules, phantom | ||
[44] | Aerts et al. | 2014 | NSCLC | ||
[45] | Balagurunathan et al. | 2014 | NSCLC | ||
[74] | Parmar et al. | 2014 | Lung cancer | ||
Image processing | [75] | Lee et al. | 2019 | Discretization, resampling | Lung cancer |
[52] | Ger et al. | 2018 | Discretization, HU threshold, filtering | Phantom | |
[57] | Shafiq-ul-Hassan et al. | 2017 | Resampling | Phantom | |
[76] | Bagher-Ebadian et al. | 2017 | Filtering | Oropharyngeal cancer | |
[41] | Larue et al. | 2017 | Discretization | Phantom | |
[56] | Mackin et al. | 2017 | Resampling, filtering | Phantom | |
[65] | Bogowicz et al. | 2016 | Discretization* | NSCLC, Oropharyngeal carcinoma | |
[60] | Fave et al. | 2016 | Resampling, filtering | NSCLC |
*In this study, CT perfusion maps were in vestigated